Literature DB >> 23973933

Hirmi Valley liver disease: a disease associated with exposure to pyrrolizidine alkaloids and DDT.

Oliver Robinson1, Elizabeth Want2, Muireann Coen2, Ruth Kennedy3, Catharina van den Bosch3, Yohannes Gebrehawaria4, Hiromi Kudo5, Fouzia Sadiq5, Robert D Goldin5, Michael L Hauser6, Alan Fenwick7, Mireille B Toledano7, Mark R Thursz8.   

Abstract

BACKGROUND & AIMS: Hirmi Valley liver disease was first reported in 2001 in Tigray, Ethiopia. 591 cases, including 228 deaths, were reported up to December 2009. The pyrrolizidine alkaloid acetyllycopsamine was detected in stored grain and residents reported adding the pesticide DDT (dichlorodiphenyldichloroethylene) directly to their food stores. We aimed to characterise the clinical features of the disease, and explore the role of these chemicals in its aetiology.
METHODS: 32 cases were examined and full clinical histories taken. Nine cases underwent liver biopsy in hospitals. Serum and urine samples were collected from cases and controls. Urine was analysed for acetyllycopsamine by UPLC-MS. Total DDT in serum was measured by ELISA. Hepatotoxicity of DDT and acetyllycopsamine alone or in combination was explored in C57BL/6J mice.
RESULTS: Clinical presentation included epigastric pain, abdominal swelling, bloody diarrhoea, hepatomegaly, splenomegaly, and ascites. Histology revealed acute injury characterised by centrilobular necrosis or chronic injury with bile ductular reaction, cytomegaly and fibrosis but no hepatic vein occlusion. Acetyllycopsamine was detected in urine samples taken in the affected area with significantly greater concentrations in 45 cases than in 43 controls (p=0.02). High levels of DDT (>125 ppb) were detected in 78% of serum samples. In mice, DDT (3 × 75 mg/kg) significantly increased the hepatotoxicity (plasma ALT, p=0.0065) of acetyllycopsamine (750 mg/kg), and in combination induced liver pathology similar to Hirmi Valley liver disease including centrilobular necrosis and cytomegaly.
CONCLUSIONS: This novel form of disease appears to be caused by co-exposure to acetyllycopsamine and DDT.
Copyright © 2013 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  AL; ALP; ALT; AST; Acetyllycopsamine; DDT; EHNRI; ELISA; Enzyme Linked Immunosorbent Assay; Ethiopia; Ethiopian Health and Nutrition Research Institute; GGT; H&E; HVLD; Hepatotoxicity; Hirmi Valley liver disease; PA; THB; Tigray Health Bureau; ULN; UPLC-MS; Ultra performance liquid chromatography – mass spectroscopy; VOD; acetyllycopsamine; alanine transaminase; alkaline phosphatase; aspartate transaminase; cyp3a; dichlorodiphenyldichloroethylene; gamma glutamyl transferase; haematoxylin and eosin; pyrrolizidine alkaloid; upper limit of normal of the laboratory reference range; veno-occlusive disease

Mesh:

Substances:

Year:  2013        PMID: 23973933     DOI: 10.1016/j.jhep.2013.07.039

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  13 in total

Review 1.  Sinusoidal obstruction syndrome (hepatic veno-occlusive disease).

Authors:  Cathy Q Fan; James M Crawford
Journal:  J Clin Exp Hepatol       Date:  2014-10-30

2.  Fasting augments pyrrolizidine alkaloid-induced hepatotoxicity.

Authors:  Jiang Ma; Chunyuan Zhang; Yisheng He; Xinmeng Chen; Ge Lin
Journal:  Arch Toxicol       Date:  2021-11-18       Impact factor: 5.153

3.  Bioassay-directed analysis-based identification of relevant pyrrolizidine alkaloids.

Authors:  Jochem Louisse; Patrick P J Mulder; Arjen Gerssen; Geert Stoopen; Deborah Rijkers; Milou G M van de Schans; Ad A C M Peijnenburg
Journal:  Arch Toxicol       Date:  2022-05-24       Impact factor: 6.168

4.  Clinical application of pyrrole-hemoglobin adducts as a biomarker of pyrrolizidine alkaloid exposure in humans.

Authors:  Jiang Ma; Wei Zhang; Yisheng He; Lin Zhu; Chunyuan Zhang; Jia Liu; Yang Ye; Yuzheng Zhuge; Ge Lin
Journal:  Arch Toxicol       Date:  2020-11-18       Impact factor: 5.153

Review 5.  The Pregnancy Exposome.

Authors:  Oliver Robinson; Martine Vrijheid
Journal:  Curr Environ Health Rep       Date:  2015-06

Review 6.  Metabolism-mediated cytotoxicity and genotoxicity of pyrrolizidine alkaloids.

Authors:  Yisheng He; Lin Zhu; Jiang Ma; Ge Lin
Journal:  Arch Toxicol       Date:  2021-05-18       Impact factor: 5.153

7.  Protective efficacy of vitamins C and E on p,p'-DDT-induced cytotoxicity via the ROS-mediated mitochondrial pathway and NF-κB/FasL pathway.

Authors:  Xiaoting Jin; Li Song; Xiangyuan Liu; Meilan Chen; Zhuoyu Li; Long Cheng; Hua Ren
Journal:  PLoS One       Date:  2014-12-02       Impact factor: 3.240

8.  Effect of aerobic exercise intervention on DDT degradation and oxidative stress in rats.

Authors:  Kefeng Li; Xiaohua Zhu; Yuzhan Wang; Shuqian Zheng; Guijun Dong
Journal:  Saudi J Biol Sci       Date:  2017-01-23       Impact factor: 4.219

9.  Khat chewing and cirrhosis in Somaliland: Case series.

Authors:  Hawa D Mahamoud; Sabah Mohammed Muse; Lewis R Roberts; Philip R Fischer; Michael S Torbenson; Tim Fader
Journal:  Afr J Prim Health Care Fam Med       Date:  2016-07-28

Review 10.  Management of hepatic vein occlusive disease after liver transplantation: A case report with literature review.

Authors:  Yuchen Hou; Nga Lei Tam; Zhicheng Xue; Xuzhi Zhang; Bing Liao; Jie Yang; Shunjun Fu; Yi Ma; Linwei Wu; Xiaoshun He
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.